Arnon Rosenthal
Net worth: 14 M $ as of 31/05/2026
Net worth: 14 M $ as of 31/05/2026
Arnon Rosenthal was the founder of Annexon, Inc. (founded in 2011, titled: Chairman from 2014 to 2017), Rinat Neuroscience Corp.
(founded in 2001, titled: President, Director & Chief Scientific Officer from 2001 to 2006), and Alector, Inc. (founded in 2013, titled: Chief Executive Officer & Director since 2019).
Former job at Genentech, Inc. as Scientist from 1985 to 2001.
Education includes a doctorate from The Hebrew University of Jerusalem.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALECTOR, INC. 5.67% | 02/06/2026 | 6,297,581 ( 5.67% ) | 14 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ALECTOR, INC. | Founder | 01/05/2013 |
| Companies | Position | End |
|---|---|---|
| ANNEXON, INC. | Chief Executive Officer | 01/12/2014 |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Founder | 01/08/2006 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/08/2001 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Annexon, Inc.
Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions